Recent Updates
Recently added Catalysts
TRI LOCUM PARTNERS LP
Track TRI LOCUM PARTNERS LP's latest SEC 13F filing: top biotech and life-sciences stock positions, portfolio weights, largest holdings, and quarter-over-quarter changes.
Updated quarterly · Last refreshed Aug 3, 2026
Showing 6 Stocks Out Of 17. Click On The Tickers For More Details
| Stock | Compnay Name | Shares Held | Market Value | % of Portfolio | QoQ Change |
|---|---|---|---|---|---|
 UTHR | UNITED THERAPEUTICS CORP DEL | 70.37 K | 41.73 M | 5.9 | |
 DFTX | DEFINIUM THERAPEUTICS INC | 369.59 K | 6.99 M | 1 | |
 AXSM | AXSOME THERAPEUTICS INC. | 62.12 K | 10.50 M | 1.5 | |
 DNTH | DIANTHUS THERAPEUTICS INC | 145.54 K | 12.21 M | 1.7 | |
 TARS | TARSUS PHARMACEUTICALS INC | 252.59 K | 17.72 M | 2.5 | |
 ARGX | ARGENX SE | 31.64 K | 23.10 M | 3.2 |
Market Value
$ 712.54 M
Holdings
17
Period
Q1 2026
Holdings in Top 20
100 %
QoQ Changes
-7.48 %